PRECLINICAL PUBLICATION · 2011

Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 21552121 ↗2011Reported benefit

RatTBIWeight-drop / impact-accelerationWistarMalen = 8-10 rats per groupintravenous50 microg/kg30 min after injury

Model: impact-acceleration diffuse TBI

Carbamylated erythropoietin reduced brain oedema up to 6 h post-injury and improved neurological recovery after diffuse TBI.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.